TrialFrontiers in immunology2021

Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.

Yulia Rodina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.